Management of stage IV rectal cancer: Palliative options
Identifieur interne : 004202 ( Ncbi/Merge ); précédent : 004201; suivant : 004203Management of stage IV rectal cancer: Palliative options
Auteurs : Sean M. Ronnekleiv-Kelly ; Gregory D. KennedySource :
- World Journal of Gastroenterology : WJG [ 1007-9327 ] ; 2011.
Abstract
Approximately 30% of patients with rectal cancer present with metastatic disease. Many of these patients have symptoms of bleeding or obstruction. Several treatment options are available to deal with the various complications that may afflict these patients. Endorectal stenting, laser ablation, and operative resection are a few of the options available to the patient with a malignant large bowel obstruction. A thorough understanding of treatment options will ensure the patient is offered the most effective therapy with the least amount of associated morbidity. In this review, we describe various options for palliation of symptoms in patients with metastatic rectal cancer. Additionally, we briefly discuss treatment for asymptomatic patients with metastatic disease.
Url:
DOI: 10.3748/wjg.v17.i7.835
PubMed: 21412493
PubMed Central: 3051134
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: 004896
- to stream Pmc, to step Curation: 004895
- to stream Pmc, to step Checkpoint: 002E67
Links to Exploration step
PMC:3051134Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Management of stage IV rectal cancer: Palliative options</title><author><name sortKey="Ronnekleiv Kelly, Sean M" sort="Ronnekleiv Kelly, Sean M" uniqKey="Ronnekleiv Kelly S" first="Sean M" last="Ronnekleiv-Kelly">Sean M. Ronnekleiv-Kelly</name></author><author><name sortKey="Kennedy, Gregory D" sort="Kennedy, Gregory D" uniqKey="Kennedy G" first="Gregory D" last="Kennedy">Gregory D. Kennedy</name></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">21412493</idno><idno type="pmc">3051134</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3051134</idno><idno type="RBID">PMC:3051134</idno><idno type="doi">10.3748/wjg.v17.i7.835</idno><date when="2011">2011</date><idno type="wicri:Area/Pmc/Corpus">004896</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">004896</idno><idno type="wicri:Area/Pmc/Curation">004895</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">004895</idno><idno type="wicri:Area/Pmc/Checkpoint">002E67</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">002E67</idno><idno type="wicri:Area/Ncbi/Merge">004202</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Management of stage IV rectal cancer: Palliative options</title><author><name sortKey="Ronnekleiv Kelly, Sean M" sort="Ronnekleiv Kelly, Sean M" uniqKey="Ronnekleiv Kelly S" first="Sean M" last="Ronnekleiv-Kelly">Sean M. Ronnekleiv-Kelly</name></author><author><name sortKey="Kennedy, Gregory D" sort="Kennedy, Gregory D" uniqKey="Kennedy G" first="Gregory D" last="Kennedy">Gregory D. Kennedy</name></author></analytic><series><title level="j">World Journal of Gastroenterology : WJG</title><idno type="ISSN">1007-9327</idno><imprint><date when="2011">2011</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p>Approximately 30% of patients with rectal cancer present with metastatic disease. Many of these patients have symptoms of bleeding or obstruction. Several treatment options are available to deal with the various complications that may afflict these patients. Endorectal stenting, laser ablation, and operative resection are a few of the options available to the patient with a malignant large bowel obstruction. A thorough understanding of treatment options will ensure the patient is offered the most effective therapy with the least amount of associated morbidity. In this review, we describe various options for palliation of symptoms in patients with metastatic rectal cancer. Additionally, we briefly discuss treatment for asymptomatic patients with metastatic disease.</p></div></front></TEI><pmc article-type="review-article"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<front><journal-meta><journal-id journal-id-type="nlm-ta">World J Gastroenterol</journal-id><journal-id journal-id-type="publisher-id">WJG</journal-id><journal-title-group><journal-title>World Journal of Gastroenterology : WJG</journal-title></journal-title-group><issn pub-type="ppub">1007-9327</issn><publisher><publisher-name>Baishideng Publishing Group Co., Limited</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">21412493</article-id><article-id pub-id-type="pmc">3051134</article-id><article-id pub-id-type="other">jWJG.v17.i7.pg835</article-id><article-id pub-id-type="doi">10.3748/wjg.v17.i7.835</article-id><article-categories><subj-group subj-group-type="heading"><subject>Topic Highlight</subject></subj-group></article-categories><title-group><article-title>Management of stage IV rectal cancer: Palliative options</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ronnekleiv-Kelly</surname><given-names>Sean M</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kennedy</surname><given-names>Gregory D</given-names></name></contrib><aff>Sean M Ronnekleiv-Kelly, Gregory D Kennedy, Department of Surgery, Section of Colon and Rectal Surgery, University of Wisconsin School of Medicine and Public Health, 600 Highland Avenue, G4/701A CSC, Madison, WI 53792, United States</aff></contrib-group><author-notes><fn><p>Author contributions: Ronnekleiv-Kelly SM and Kennedy GD wrote the manuscript.</p><p>Correspondence to: Gregory D Kennedy, MD, PhD, Department of Surgery, Section of Colon and Rectal Surgery, University of Wisconsin School of Medicine and Public Health, 600 Highland Avenue, G4/701A CSC, Madison, WI 53792, United States. <email>kennedyg@surgery.wisc.edu</email></p><p>Telephone: +1-608-2632521 Fax: +1-608-2637652</p></fn></author-notes><pub-date pub-type="ppub"><day>21</day><month>2</month><year>2011</year></pub-date><pub-date pub-type="epub"><day>21</day><month>2</month><year>2011</year></pub-date><volume>17</volume><issue>7</issue><fpage>835</fpage><lpage>847</lpage><history><date date-type="received"><day>30</day><month>8</month><year>2010</year></date><date date-type="rev-recd"><day>4</day><month>1</month><year>2011</year></date><date date-type="accepted"><day>11</day><month>1</month><year>2011</year></date></history><permissions><copyright-statement>©2011 Baishideng Publishing Group Co., Limited. All rights reserved.</copyright-statement><copyright-year>2011</copyright-year></permissions><abstract><p>Approximately 30% of patients with rectal cancer present with metastatic disease. Many of these patients have symptoms of bleeding or obstruction. Several treatment options are available to deal with the various complications that may afflict these patients. Endorectal stenting, laser ablation, and operative resection are a few of the options available to the patient with a malignant large bowel obstruction. A thorough understanding of treatment options will ensure the patient is offered the most effective therapy with the least amount of associated morbidity. In this review, we describe various options for palliation of symptoms in patients with metastatic rectal cancer. Additionally, we briefly discuss treatment for asymptomatic patients with metastatic disease.</p></abstract><kwd-group><kwd>Palliative therapy</kwd><kwd>Rectal cancer</kwd><kwd>Malignant bleeding</kwd><kwd>Malignant obstruction</kwd><kwd>Endorectal stenting</kwd><kwd>Laser ablation</kwd></kwd-group></article-meta></front></pmc><affiliations><list></list><tree><noCountry><name sortKey="Kennedy, Gregory D" sort="Kennedy, Gregory D" uniqKey="Kennedy G" first="Gregory D" last="Kennedy">Gregory D. Kennedy</name><name sortKey="Ronnekleiv Kelly, Sean M" sort="Ronnekleiv Kelly, Sean M" uniqKey="Ronnekleiv Kelly S" first="Sean M" last="Ronnekleiv-Kelly">Sean M. Ronnekleiv-Kelly</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004202 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 004202 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Ncbi
|étape= Merge
|type= RBID
|clé= PMC:3051134
|texte= Management of stage IV rectal cancer: Palliative options
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:21412493" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |